CTRI/2023/02/049425已完成4 期
An Open label, Clinical Safety and Efficacy Study for evaluation of Hair oil in reduction in hairfall, reduction in dandruff and hair growth in healthy adult subjects.
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Subjects with Hair loss problems,mild to moderate dandruff and thinning of hair.
- •2. Healthy Adult Volunteers of =18 to = 50 years inclusive of both genders
- •3. Subjects generally in good health and willing to give written
- •informed consent and willing to follow the study procedure will be enrolled in the study
- •4. Subjects with hair all count of 40-50 for females and 25-30 for males as evaluated by 60secs comb test .
排除标准
- •1.History of any dermatological conditions of the scalp (other than dandruff or seborrheic dermatitis or hair loss) that would interfere with the diagnosis or assessment (e.g. psoriasis,
- •eczema, atopic dermatitis, or other skin/scalp infections).
- •2. Subjects with excessive erythema, crusting or a significant
- •number of pustules/papules on the scalp.
- •3. History ofskin cancer or treatment for any type of cancer within the last 2 years.
- •4. History of prior use of antidandruff treatment on scalp within past 1 month.
- •5. Participation in a similar clinical study within the previous 90 Days.
研究者
相似试验
尚未招募
3 期
A clinical trial to study the effects of combined therapy with Docetaxel and Doxorubicin in female patients with metastatic breast cancerCTRI/2014/01/004344CJSC RCI Syntez Russia40
尚未招募
4 期
Clinical Efficacy and safety of Sanjeevini ThailamCTRI/2018/02/011941Isha Arogya Pvt Ltd
进行中(未招募)
不适用
An open-label study evaluating safety and efficacy of recombinant human nerve growth factor (rhNGF) eye drops at different doses in patients with Dry EyeEUCTR2013-004271-12-ATDompé s.p.a
进行中(未招募)
1 期
Patisiran-LNP in Patients with hATTR Amyloidosis Disease Progression Post-Liver TransplantHereditary Transthyretin-mediated Amyloidosis (hATTR amyloidosis)MedDRA version: 20.0Level: PTClassification code 10007509Term: Cardiac amyloidosisSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10019889Term: Hereditary neuropathic amyloidosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2018-003519-24-DEAlnylam Pharmaceuticals, Inc.20
进行中(未招募)
1 期
Patisiran-LNP in Patients with hATTR Amyloidosis Disease Progression Post-Liver TransplantEUCTR2018-003519-24-ITALNYLAM PHARMACEUTICALS, INC.20
